These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28362706)

  • 1. Prostate Ductal Adenocarcinoma.
    Amin A
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):514-521. PubMed ID: 28362706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
    Au S; Villamil CF; Alaghehbandan R; Wang G
    Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
    Morais CL; Herawi M; Toubaji A; Albadine R; Hicks J; Netto GJ; De Marzo AM; Epstein JI; Lotan TL
    Prostate; 2015 Oct; 75(14):1610-9. PubMed ID: 26178158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations.
    Fine SW
    Adv Anat Pathol; 2012 Jul; 19(4):204-16. PubMed ID: 22692283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal Spread Versus High-Grade Prostatic Intraepithelial Neoplasia: A Diagnostic Pitfall.
    Acosta AM; Sharif A; Groth JV; Kajdacsy-Balla A
    Int J Surg Pathol; 2016 Dec; 24(8):718-719. PubMed ID: 27605089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers.
    Tarján M; Chen HH; Tot T; Wu W; Lenngren A; Dean PB; Tabár L
    Scand J Urol Nephrol; 2012 Aug; 46(4):258-66. PubMed ID: 22519924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic ductal adenocarcinoma showing Bcl-2 expression.
    Tulunay O; Orhan D; Baltaci S; Gögüş C; Müftüoglu YZ
    Int J Urol; 2004 Sep; 11(9):805-8. PubMed ID: 15379952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic prostatic ductal adenocarcinoma: an unusual presentation and cytological diagnosis.
    Henderson-Jackson E; Sexton W; Zhang J; Hakam A; Petrovskyy VS; Bui MM; Chuang ST
    Ann Clin Lab Sci; 2012; 42(1):81-8. PubMed ID: 22371914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential expression of LLGL2 in prostate ductal adenocarcinoma and acinar adenocarcinoma and its significance].
    Zhang W; Wang M; Liu LT; Cui D; Liu M; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1012-1016. PubMed ID: 37805392
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraductal Carcinoma of the Prostate Gland: Recent Advances.
    Divatia MK; Ro JY
    Yonsei Med J; 2016 Sep; 57(5):1054-62. PubMed ID: 27401634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure prostatic papillary adenocarcinoma with ductal features.
    Yamashita S; Inaba Y; Soma F; Katayama Y
    Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal adenocarcinoma of prostate-A diagnostic dilemma.
    Sharma S; Kakkar N; Devana SK
    Indian J Pathol Microbiol; 2020; 63(4):674-675. PubMed ID: 33154339
    [No Abstract]   [Full Text] [Related]  

  • 13. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.
    Seipel AH; Delahunt B; Samaratunga H; Egevad L
    Pathology; 2016 Aug; 48(5):398-405. PubMed ID: 27321992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. My approach to intraductal lesions of the prostate gland.
    Pickup M; Van der Kwast TH
    J Clin Pathol; 2007 Aug; 60(8):856-65. PubMed ID: 17237185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Origin and Tumor Heterogeneity of Prostatic Ductal Adenocarcinoma in the Han Chinese Population.
    Zhang W; Su F; Wang M; Hou H; Liu M; Liu D; Liu H
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):727-732. PubMed ID: 34788144
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostatic duct carcinoma with combined prostatic duct adenocarcinoma and urothelial carcinoma features: report of a case.
    Pacchioni D; Casetta G; Piovano M; Fraire F; Volante M; Sapino A; Tizzani A; Bussolati G
    Int J Surg Pathol; 2004 Jul; 12(3):293-7. PubMed ID: 15306945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Diagnosis of Intraductal Lesions of the Prostate.
    Wobker SE; Epstein JI
    Am J Surg Pathol; 2016 Jun; 40(6):e67-82. PubMed ID: 26848801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare histological patterns of prostatic ductal adenocarcinoma.
    Lee TK; Miller JS; Epstein JI
    Pathology; 2010 Jun; 42(4):319-24. PubMed ID: 20438402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical verification of ductal differentiation in prostate cancer.
    Tarján M; Lenngren A; Hellberg D; Tot T
    APMIS; 2012 Jun; 120(6):510-8. PubMed ID: 22583364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.